including kidney, inner ear, teeth, cortical patterning in the brain and eyelid closure. 7 Loss of SPRY1 causes specific phenotypes similar to those observed in case of growth factor overdose. 8 In addition, SPRY1 may affect tumour cell function through direct interaction with urokinase plasminogen activator receptor and promote its lysosomal degradation. 9 SPRY proteins have a crucial role in the regulation of TGF-β-induced lens epithelial mesenchymal transition (EMT). 10 Overexpression of SPRY1 prevents VEGF secretion and suppresses growth, migration and invasion of human breast cancer cells. 11 SPRY1
is downregulated in a variety of cancer types, including breast, prostate, liver, lung and thyroid cancers, 12 especially in metastatic malignant stages involving EMT. 13 However, it was also reported that SPRY1 mRNA and protein levels were rather increased in the malignant tissue of lung cancer patients. 14 Therefore, the role of SPRY1 was controversial in view of the occurrence and progression of malignancies. Although the mechanism by which they function biochemically is still subject of investigation, it is clear that SPRY1 can antagonize RTK signalling. SPRY1 has also diverse cellular functions, such as antiproliferative activity, inhibition of migration, supporting differentiation and survival. 1, 15 Despite recent advances in the understanding of roles of SPRY1 on the regulation of FGF receptor signalling in embryogenesis, 16 the role of SPRY1 in human skin remains widely unknown. As the inhibitory function of SPRY1 is cell and ligand specific, 4 we examined whether SPRY1 affects the differentiation, proliferation, apoptosis and invasion capability of human normal epidermal keratinocytes in vitro and in wound healing, contact hypersensitivity and acute inflammatory responses in K14-SPRY1 transgenic mouse model in vivo.
| MATERIAL S AND ME THODS

| Reagents and antibodies
Antibodies against SPRY1 (1:1000 dilution), β-actin, E-cadherin, Ncadherin and vimentin were purchased from Santa Cruz Bio-technology, 
| Skin sample collection
After obtaining approval by the ethics committee of the Zhejiang University, School of Medicine, 12 donors (mean age 32.6 ± 10.5)
undergoing plastic surgery for cosmetic reasons were invited to participate the study. All individuals provided written informed consent.
A 1-2 cm surgical biopsy from donors' non-sun-exposed extremities and/or backs' skin was taken.
| Immunohistochemistry and Immunofluorescence
For immunohistochemistry (IHC) staining of SPRY1, involucrin and Ki67, OCT embedded sections were used. Slides were then blocked with normal rabbit or goat serum (Vector Laboratories, Burlingame, CA, USA) and incubated with primary antibody followed by incubation with biotinylated rabbit anti-rat IgG or biotinylated goat anti-rabbit IgG and treatment of AB complex (Vector Laboratories, Burlingame, CA, USA). Staining was finally visualized with DAB high-sensitivity substrate chromogen solution (Vector Laboratories, Burlingame, CA, USA) and counterstained with haematoxylin.
Immunofluorescence assay was carried out as described in detail before. 17 Briefly, skin biopsy specimens (n = 3) were processed, fixed, preheated and blocked using 10% 
| Human embryonic kidney (HEK) 293T cells and primary keratinocytes culture and treatment
HEK293T cells less than 10 passages were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS at 37°C in a humidified atmosphere of 5% CO 2 and acted as a tool cell to transfect and produce sufficient lentivirus for further NHEK transfection. NHEK were prepared from skin incubated with dispase as previously described, 18 except for the culture medium was replaced by serum-free medium from Millipore. Second passage with confluence status of NHEK was used in this study except indicated.
| Quantitative real-time PCR (qRT-PCR) and PCR analysis
Total RNA was isolated from epidermis of WT and SPRY1-TG mice by using TRIzol reagent (Invitrogen, Carlsbad, CA, USA). qRT-PCR was done according to previous description. 19 CT values were analysed by qBase Plus 2 software (Biogazelle, Zwijnaarde, Belgium).
| Lentiviral infection
The lentiviral vectors were obtained from Applied Biological Materials (ABM) Inc (Richmond, BC, Canada). The amplification, packaging and infection of the lentiviral vectors were carried out according to the manufacturer's protocol. Briefly, lentiviral vectors were firstly amplified by using standard Escherichia coli DH5α strain transformation protocols. Then, the isolated vectors were diluted with ABM's Second Generation (LV003) Packaging Mix in serumfree medium and mixed with LentiFectin™ Transfection reagent. To produce human SPRY1 lentiviruses, HEK293T cells were transfected with a lentiviral vector plenti-GIII-CMV-hSPRY1-GFP-2A-puro and packaging plasmids. Blank control lentivector, pLenti-CMV-GFP-2A-Puro-Blank Vector (LV590), was used as control. Then, the supernatant was harvested and subsequently virus tittering at 10 6 IU/mL was used to infect NHEK. At 48 h after infection, 2 μg/mL puromycin was added to select virally infected cells for further experiments.
Expression of SPRY1 was assayed by qRT-PCR and Immunoblot.
| Western blot analysis
Cells were lysed with RIPA buffer and lysates were boiled with with an overall significance level of less than 0.05. 
| Cell proliferation assay
| Transwell invasion assay
The transwell invasion assay was performed by using the Cells on the lower surface of the insert were fixed by 4% PFA and nuclei were labelled with DAPI. Each cell line was plated in triplicate.
The invaded cells were counted in five fields under the fluorescent microscope at 40x magnification. 
| Apoptosis assay
| Mouse line
| Mouse epidermis acquiring
After sacrifice, mice dorsum skin was removed and cut into pieces.
After incubating with 0.5% dispase in 4°C overnight, dermis of skin removed and part of the epidermis were utilized for total epidermis proteins and mRNA extraction as routine.
| Skin wound healing assay in mice
Six SPRY1 TG female mice (7-week-old) were used for the study.
Age-and sex-matched WT mice (n = 6) were used as controls.
Four full-thickness excisional wounds (6 mm in diameter) on the back skin were generated by sterile disposable biopsy punches (AcuPunch ® , Acuderminc. NW, USA). The circle pieces of skin were removed by surgical forceps. The day when the punch biopsy was taken recorded as day 0. Photographs were taken using a digital camera (Nikon Corp., Tokyo, Japan) at day 0, 3, 6, 9 and 12 after the biopsy. Wounds were also monitored and measured by callipers. Length and width of the wounds were used to calculate the wound area in mm 2 . Healing was defined as the decrease in wound diameter over time and was expressed as the percentage of the day-0 wound diameter.
| Haematoxylin and eosin (H&E) staining and masson trichrome staining
Mouse skin tissue a specimen was fixed in 10% freshly prepared buffered formalin for 24 h and embedded in paraffin. Sections were cut using a microtome, and collected on superfrost plus slides. The sections were then rehydrated by gradual immersion in 70%, 80%, 95% and 100% ethanol, cleared with xylene and finally stained with H&E staining. Images were taken with an Olympus DP70 camera system (Olympus, Tokyo, Japan). The masson trichrome staining procedure was performed with the operation manual of the masson trichrome staining kit (Solarbio life science, Beijing, China).
| iTRAQ (isobaric tags for relative and absolute quantification)-based proteomic analysis
Epidermis proteins separated from mouse whole skin (n = 4, Spry1 TG mice and WT mice group) after digestion in 0.25% dispase at The protein quantification results were statistically analysed by Mann-Whitney Test, the significant ratios, defined as P < .05 and |log 2 FC| >0.585 (ratio >1.5 or ratio <0.67 [fold change, FC]), were used to screen the differentially expressed proteins (DEPs).
The functional analysis of protein and DEPs with Gene Ontology (GO). GO enrichment statistically analysed by Fisher's exact test.
| Statistical analysis
Statistical analyses were performed using SPSS software version 
| RE SULTS
| Expression of SPRY1 in normal skin and cultured NHEK
To investigate the expression profile of SPRY1 in normal epidermis, immunohistochemistry (IHC) staining against SPRY1 was performed in specimens obtained from three healthy donors, who had signed prior informed consents. According to the results, SPRY1 was mainly detected in epidermis and primarily continuously expressed in the granular layer. In the basal layer, it was only marginal detectable ( Figure 1A ). Furthermore, we detected the keratinocytes' terminal differentiation marker of involucrin by IHC and together with SPYR1 by immunofluorescence (IF). As shown in Figure 1A and B, SPRY1 was located in the upper stratum granular compared with involucrin. To further ascertain the localization of SPRY1 in the subcellular compartments, primary cultured NHEK were obtained from healthy donors. As shown in Figure 1C 
| Forced overexpression of SPRY1 established in NHEK
In order to better understand the features of SPRY1 in the epidermis, we established SPRY1-overexpressed NHEK. We took advantage of the widely used polybrene-mediated infection of lentivirus for SPRY1 overexpression in NHEK and followed an optimized protocol with slight modifications. We obtained efficient infection in >80% verified by fluorescence microscopy in both SPRY lentivirus (SPRY1 LV) and blank control lentivirus (control LV) groups (Figure 2A ). At mRNA level, SPRY1
increased more than 400-folds in cultured keratinocytes compared to control ( Figure 2A ). More than 10-folds increase in SPRY1 at protein level was detected in SPRY1 LV-transfected keratinocytes compared to control LV-infected cells (Figure 2A ).
| Overexpressed SPRY1 inhibited cell proliferation and promoted apoptosis of NHEK
After SPRY1-overexpressed primary cultured keratinocytes being established, we further examined the role of SPRY1 in cell function of NHEK. As shown in Figure 2B , MTT assay was used to investigate cell proliferation of SPRY1 overexpressed NHEK and increased SPRY1 inhibited primary keratinocytes' proliferation compared to controls (P < .001). In addition, the mitosis-regulation proteins cyclin B1 (CYCB1) and G0/G1 switch gene 2 (G0S2) were remarkably decreased in SPRY1-overexpressed NHEK at protein level ( Figure 2B ). Cell cycle-related proteins such as p21, p27, and p53 exert an important role in the cell cycle or apoptosis. In our study, p21 and p27 were slightly increased under SPRY1 overexpression in NHEK, while phospho-p53 and p53 did not change notably ( Figure 2B ).
We further analysed the apoptosis of SPRY1-overexpressed keratinocytes through FACS. Our results showed that the population of annexin V single-positive apoptotic cells was markedly increased in the SPRY1 LV group as compared to the control LV group (9.03% vs 3.8%, P < .01) ( Figure 2C ). Up-regulation of SPRY1 resulted in an increased number of cells undergoing apoptosis, suggesting that SPRY1 contributes to apoptosis of keratinocytes.
| SPRY1 and differentiation of NHEK
As SPRY1 is primarily expressed in the granular layer, we assumed that SPRY1 may be associated with the differentiation of keratinocytes. As shown in Figure 2D , protein levels of the differentiation markers of the epidermal keratinocytes, keratin 10 (K10) and 1 (K1),
were not affected by overexpression of SPRY1. Involucrin is a minor component of cornified envelope (CE) and expressed in stratified squamous epithelia in the upper spinous and granular layer. 20, 21 In this study, involucrin was not changed upon overexpression of SPRY1 in NHEK. Interestingly, overexpressed SPRY1 up-regulated loricrin in NHEK ( Figure 2D ), which is considered as a later differentiation marker of NHEK. 20 Therefore, our results suggested that overexpressed SPRY1 may be associated with later differentiation of NHEK which was indicated by the fact that SPRY1 was located primarily in granular layer of epidermis.
| Overexpression of SPRY1 in NHEK-inhibited cell migration
To further evaluate the role of SPRY1 in keratinocytes, we conducted a transwell assay to examine the migration of SPRY1-overexpressed epidermal keratinocytes. Our results indicated that migrated SPRY1-overexpressed cells were much less than control counterparts, which was significantly reduced about by 29.9% (P < .01) in 24 hours
( Figure 2E ). PAI-1, a secreted protein that belongs to the serine proteinase inhibitor superfamily and interacts with the extracellular matrix (ECM) components, was up-regulated; but integrin α6 being decreased, under the condition of SPRY1 overexpression in NHEK.
In addition, protein levels of matrix metalloproteinase 3 (MMP3), a family member of MMPs degrading proteoglycan in ECM, were also decreased somewhat in the SPRY1 LV group ( Figure 2F ).
| Establishment of K14-SPRY1 transgenic mice
In order to study the function of SPRY1 in vivo, we established skin specifically overexpressed SPRY1 transgenic (SPRY1-TG) mice with the gene profile K14-SPRY1. The SPRY1-TG mice expressed SPRY1 in the tissue or cells with keratin 14 expression, such as epidermis. Firstly, we determined SPRY1 at DNA and protein levels.
As shown in Figure 3A , the genomic DNA of SPRY1 was indicated at 330 bp in SPRY1 TG by PCR compared to wild-type and Rsg7
(632 bp) selected as internal control gene. Western blot result further confirmed overexpressed SPRY1 in the epidermis of SPRY1 TG mice ( Figure 3A ). Immunohistochemistry and immunofluorescence were performed in SPRY1 TG skin (samples gained from the dorsum). As shown in Figure 3B , SPRY1 was continuously expressed in the epidermis (especially under the stratum corneum) of SPRY1 TG mice. In the zoomed image, it is recognizable that SPRY1 protein was located in cytoplasm, just the same as in NHEK. These results demonstrated that K14-SPRY1 transgenic mice were successfully established. Both male and female transgenic mice were fertile.
| Cell cycle and differentiation-associated proteins of epidermis altered in SPRY1 transgenic mice
To confirm the role of SPRY1 in cell cycle and differentiation in vivo, expression of associated proteins was detected in the epidermis of SPRY1 transgenic mice and wild-type mice. Epidermis-derived sample tissues were obtained from both SPRY1 TG and WT mouse skin, then cell cycle, differentiation-associated proteins were detected by western blot. Figure 3C demonstrated epidermis-derived cell cycle-related proteins, p27, p53 and p-p53, were notably overexpressed in SPRY TG that consistent with mRNA level by qRT-PCR. However, cyclinB1 and G0S2 did not change at mRNA level.
Results in
F I G U R E 2
Overexpression of SPRY1 inhibited cell grow and proliferation while promoted apoptosis in NHEK. A, Images of NHEK cells transfected with SPRY1 LV and control after 24 h observed by fluorescence microscopy. The transfection rate was over 80% in all experiments as demonstrated by GFP production. Scale bar = 200 μm. D, mRNA relative expression levels of SPRY1 in NHEK transfected with control vector and SPRY1-overexpressed vector by qRT-PCR. Protein levels of SPRY1 LV and control LV transfected NHEK by western blot analysis. β-actin was used as internal control. The histogram showed quantification of SPRY1 protein levels in two groups. Ctl: control; LV: lentivirus; In histograms, data were showed as mean±SEM and student t test was used. *P < .05, ***P < .001. B, Comparison of cell proliferation in SPRY1 LV and control LV-transfected primary keratinocytes after 24 hours by MTT assay. Optical density value (O.D) at 490 nm was used for quantitative (n > 3 in each group, ***P < .001). Cell cycle-related proteins (P21, P27, CYCB1, G0S2, P53 and p-P53) were detected in SPRY1 LV and control LV group by western blot and β-actin used as internal control. Alteration of differentiationassociated proteins of keratinocyte (keratin1, keratin10, involucrin and loricrin) expression was measured by western blot with β-actin used as internal control. C, Representative images of overexpressed SPRY1 in primary keratinocytes on the cell apoptosis rate determined by FACS. The annexin V and PI both positive cells are the cells undergoing apoptosis and are represented in the upper right quadrant. The mean apoptosis rate of SPRY1 LV group is 9.03% vs 3.8% in the controls and the right histogram shows quantification of apoptosis cell rate between the two groups (**P < .01). D, The expression of differentiation markers K1, K10, loricrin and involucrin in SPRY1 LV and control determined by Western blot. E, Immunofluorescence images of transwell assay indicated migration capability was applied in keratinocytes with forced overexpression of SPRY1. The right histogram showed quantification of at least 10 randomly selected fields after 24 h for rates of transfected cells in transwell assay. Scale bar = 100 μm. Blue: DAPI; **P < .01.) F, Western blot analyse the effect of up-regulated SPRY1 in primary keratinocytes on the levels of cell adhesion-related proteins (integrin-α6, MMP3 and PAI-1). β-actin was used as internal control.
Representative data from three independent experiments are shown
Terminal differentiation makers, k1 and k10, which are localized in spinous and granular layers, were decreased in the epidermis of SPRY1 TG mice ( Figure 3D ). Furthermore, the proliferation marker K14 decreased in SPRY1 TG while apoptosis marker of caspase 3 increased ( Figure 3E ). These results indicated that SPRY1 might play a role in the terminal epidermal differentiation and has the similar role in vivo as in cultured human primary keratinocytes. Overexpression of SPRY1 in the epidermis or keratinocytes suppresses cell proliferation, cell migration, promote cell apoptosis and may contribute to later differentiation of keratinocytes.
| SPRY1 TG mice exhibited delayed skin wound healing
To elucidate whether SPRY1 could act as a suppressor of the epithelial growth, we performed wounding experiments in WT and SPRY1 TG mice. Specifically, four wounds diameter six millimetre (mm) were punched on the shaved dorsum of each mouse ( Figure 4A ). Wounded skin was harvested at 3, 6 and 9 days after the punch ( Figure 4B ). The average wound area in the experimental mice of WT (SPRY1 TG) was 13.9 (18.7), 6.9 (12.7) and 2.7 (5.4) mm 2 , at day 3, 6 and 9 after wound injury. Skin healing F I G U R E 3 Confirmation of overexpressed SPRY1 protein in the transgenic mice. A, Genotyping was performed by PCR products electrophoresis. The left line was DNA markers, 330 bp band was SPRY1 and Rsg7 (632 bp) was selected as internal control. Western blot analysis of tissue samples from epidermis of SPRY1-TG and WT. β-actin was used as internal control. B, SPRY1 expression by immunofluorescence and immunochemistry staining of mice skin from SPRY1-TG and WT mice respectively. The tissue sections were also stained with DAPI to visualize the nuclei. Scale bar = 100 μm for all panels. C, qRT-PCR analysis relative mRNA expression of cell cycle-associated genes (p21, p27, cyclinb1, g0s2, p53) in SPRY1-TG and WT mice skin. Vertical axis indicated relative expression of mRNA by GAPDH as control. n.s: no statistically significant. ***P < .001. Symbols indicate mean mean ± SEM of six mice per group with student t test. D,E, Images of western blot showed alteration of cell cycle-related proteins (P27, P21, p-P53), EMT-related proteins (K1/K10, β-catenin, MMP3 and K14 and caspase-3. β-actin was used as internal control (Lysate was obtained from epidermis of SPRY1 TG and wildtype mice)
delayed at these days in the SPRY1 TG group compared to the WT group with significant statistical difference at day 3 (P < .01), 6 (P < .001) and 9 (P < .01) ( Figure 4B ). In addition, masson staining of wound tissue sections revealed that SPRY1 TG mice had more severe haemorrhages and more delayed wound healing than WT mice ( Figure 4C ). Especially at day 3, blood vessels in the granulation tissue of SPRY1 TG mice were much more than those in WT mice (P < .05) under microscopy ( Figure 4C ). To illustrate the role of SPRY1 in wound healing, we further performed IHC analysis of proliferation marker Ki67 and western blot of myofibroblast differentiation marker α-SMA in the wound area. As showed in Figure 4D , less Ki67-positive cells were detected in SPRY1 TG group while α-SMA upregulated at day 3 and day 6 after punching.
This result indicated that SPRY1 may affect the proliferation of epidermis and the maturity of granulation tissue after skin wounded.
| Proteomic analysis reveals SPRY1 related to epidermal immune-and inflammatory-associated biological processes
iTRAQ was used to detect the differentially expressed proteins (DEPs) in SPRY1 TG mice' epidermis compared to WT (n = 4 in each group). According to the experimental data, 2751 proteins were detected and 129 of them were DEPs. As showed in Figure 5A , 82 DEPs were up-regulated in SPRY1 TG mice compared to WT and 47 DEPs were down-regulated. Furthermore, based on the GO-enrichment analysis of biological process of DEPs in SPRY1 TG mice, we found that DEPs are significantly enriched in immune-and inflammatory-associated biological process such as immune response (GO:0006955, P = .0421 P < .05), innate immune response (GO:0045087, P = .0468 P < .05), metabolic processes as well, especially retinoid metabolic process (GO:0001523, P = .0004 P < .001) and steroid metabolic process (GO:0008202, P = .0289 P < .005)( Figure 5B ). Additionally, heatmap in Figure 5C presented that pro-inflammatory cytokines and receptors IL-1α 
| D ISCUSS I ON
It is now well established that SPRY proteins inhibit signalling from various growth factor receptors, including epidermal growth factor (EGF), fibroblast growth factor (FGF), vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF) and glial cellderived neurotrophic factor (GDNF). 22, 23 As during development, expression of SPRY proteins is mainly observed at sites of known growth factor signalling, a negative feedback loop was also postulated. 24 SRPY1 has also been proposed to function as a tumoursuppressor gene in various malignancies, including prostate cancer, 25 hepatocellular carcinoma and thyroid carcinoma. 26 However, controversial results evidenced that the level of SPRY1 altered inconsistently in different experiments based on various contexts. 24 The concise functions of SPRY1 in epidermal keratinocytes were not determined so far. Therefore, we investigated the role of SPRY1 in the epidermal biology preliminarily. Firstly, we found SPRY1 in Therefore, it seems that SPRY1 may inhibit cell proliferation but promote apoptosis in the epidermal keratinocytes.
To further define the underlying mechanism behind the role of SPRY1 in keratinocyte proliferation, cell cycle-associated markers were investigated next. P21 and P27 are well-known cell cycle inhibitors. In our study, we detected an increase in the expression of the P27 and P21 in SPRY1 LV cells. Cyclin B1 is a family member of proteins that activate specific cyclin-dependent kinases required for progression through the cell cycle. Decreased cyclin B1 together with increased P21 and P27 would affect the cell cycle progression in the SPRY1 overexpressed NHEK. G0S2 is a basic protein that was identified as an early activating gene in a screen of lectin-activated human lymphocytes. 27 Results from a limited number of studies have implied that G0S2 is a multifaceted protein involved in proliferation, apoptosis and carcinogenesis. 27 In human primary fibroblasts, G0S2 interacts with Bcl-2, promoting apoptosis by preventing the formation of Bcl-2/Bax heterodimers. 17 In our study, forced overexpression of SPRY1 induced a decrease in G0S2. Furthermore, we detected apoptosis marker of caspase 3 and proliferation marker of K14 in epidermis of SPRY1 transgenic mice and caspase 3 increased while K14 increased when compared to WT. Therefore, based on these data, we suggest that SPRY1 may inhibit proliferation and promote apoptosis through regulating cell cycle-associated protein.
Transwell results showed less migration in SPYR1-overexpressed NHEK. Till now, little is known about SPRY1 and migration. Here, we investigated the association between SPRY1-and ECM-associated components, including MMP3, PAI-1 and integrin α6. MMP3 is a | 11 of 13
family member of peptidase enzymes responsible for the degradation of ECM components. PAI-1 is transcriptionally regulated by TGF-β and mediates TGF-β-induced inhibition of cell migration and invasion in cancer cells. 28 Integrins play a crucial role in epithelial cell-cell adhesion and cell-matrix interaction. 29, 30 In the SPRY1 LV keratinocytes, MMP3 and integrin α6 were decreased while PAI-1 was up-regulated. That is, SPRY1 may regulate migration of keratinocytes through modulating production of ECM and alteration of cell adhesion as well.
As SPRY1 in normal epidermis was mainly in the granular layer, and most of the differentiation markers are localized in this layer, we hypothesized that SPRY1 may also be associated with differentiation F I G U R E 4 Delayed wound healing process was observed in SPRY1 transgenic mice. A, The graph showed establishment profile of wound healing models, wound tissue sections were harvested at day 0, 3, 6 and 9 post-injury; Lower picture demonstrated diameter with 6 mm : numbers (data indicated mean score ± SEM, n = 6 at least six mice per group with student t test. *P < .05; **P < .01; ***P < .001)
The epidermal proteomics in SPRY1 TG mouse. A, Volcano map demonstrated the up-and down-regulated proteins in SPRY1 TG mice epidermis compared to WT. The green dots represented down-regulated proteins (n = 42) and red represented up-regulated proteins (n = 82). B, The histogram shows GO-enrichment analysis DEPs in Biological Process. Every column shows all detected proteins enriched to GO term, including up-regulated DEPs (red), down-regulated DEPs (blue) and non-DEPs (grey). GO term: immune response (GO:0006955, P = .0421), innate immune response (GO:0045087, P = .0468, retinoid metabolic process (GO:0001523, P = .0004) and steroid metabolic process (GO:0008202, P = .0289). (*P < .05, **P < .01, ***P < .001). C, Heatmap depicting the relative abundance of six detected proteins, which enrich to Biological Process: inflammatory response (GO:0006954) identified from epidermis of Spry1 TG and WT (n = 4). On the right of heatmap showed encoded genes of proteins. K14-SPRY1 mice were generated to further clarify the role of SPRY1 in the epidermal biology in vivo. By detecting associated markers in epidermis, the in vivo results were in accordance with the in vitro, which showed decreased proliferation and promoted differentiation by SPRY1 overexpression. An orchestrated cascade of biochemical events will be set into motion to repair skin damage. This process includes haemostasis, inflammation, tissue growth (cell proliferation) and maturation. In our study, we performed wound healing in mice and results showed that SPRY1 TG mice demonstrated a delayed healing process, which may be due to the functions of SPRY1 in inhibiting cell proliferation, migration and promoting apoptosis in keratinocytes. As Ki-67-positive basal layer keratinocytes in SPRY1 TG after wounded were much less than WT, while the myofibroblast differentiation marker α-SMA was up-regulated, the epidermal migration and granulation tissue maturity were delayed in SPRY1 TG mice. In conclusion, based on the evidence that comes from in vitro overexpression-derived data in keratinocytes, and epidermal expressed SPRY1 TG mouse in vivo, we suggest that SPRY1 possesses potential characteristics of anti-proliferative, anti-migrate, antiinflammatory effects and pro-apoptotic effects. These effects may be associated with SPRY1-regulated cell cycle protein, integrin α6, MMP3 and PAI-1. Similar effects on epidermal proliferation, differentiation and wound healing have been observed for transcription factors such as p63, KLF4, CTIP2 and CTIP1, which might regulate cell signalling in a similar manner as SPRY1. [31] [32] [33] [34] [35] [36] The role of SPRY1 in the pathogenesis of wound healing and proliferative skin diseases, such as psoriasis, and its interaction with the above transcription factor, deserves extensive research in the next future.
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